Literature DB >> 1267273

Sepsis complications in endoscopic retrograde cholangiopancreatography.

E C James, D B Collin.   

Abstract

The overall complications rate with endoscopic retrograde cholangiopancreatography (ERCP) has been justifiably small. However, serious septic sequelae have resulted in extended morbidity and occasional mortality. This occurs following successful cannulation and the injection of contrast media in two clinical conditions: (1) when ductal obstruction impairs proper drainage and (2) when a pseudocyst is injected. The initial experience at Walter Reed and Madigan Army Medical Centers with 71 attempted ERCP procedures includes two cases of pseudocyst abcess. Although this represents only a 2.8 per cent overall incidence of infection, it constitutes a 33.3 per cent rate in the six patients with pseudocysts evaluated. Therefore, it is recommended that routine ERCP be contraindicated in suspected pseudocysts.

Entities:  

Mesh:

Year:  1976        PMID: 1267273

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  7 in total

Review 1.  Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy.

Authors:  S P Povoski; M S Karpeh; K C Conlon; L H Blumgart; M F Brennan
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

2.  [Microbiological studies before and after endoscopic papillotomy (EPT)].

Authors:  R Ansorg; U R Fölsch; N Kieslich; R Arnold
Journal:  Infection       Date:  1983 Sep-Oct       Impact factor: 3.553

Review 3.  Gastrointestinal instrumentation, bacteraemia, and endocarditis.

Authors:  P J Shorvon; S J Eykyn; P B Cotton
Journal:  Gut       Date:  1983-11       Impact factor: 23.059

Review 4.  Complications of gastrointestinal radiologic procedures: II. Complications related to biliary tract studies.

Authors:  D J Ott; D W Gelfand
Journal:  Gastrointest Radiol       Date:  1981-01-15

Review 5.  Gastrointestinal endoscopy: infection and disinfection.

Authors:  H J O'Connor; A T Axon
Journal:  Gut       Date:  1983-11       Impact factor: 23.059

6.  Elimination of bacteria in biliary tract infections during ceftizoxime therapy.

Authors:  E B Helm; D Wurbs; R Haag; D Bentele; P M Shah
Journal:  Infection       Date:  1982       Impact factor: 3.553

7.  Risk factors of post endoscopic retrograde cholangiopancreatography bacteremia.

Authors:  Min-Sun Kwak; Eun Sun Jang; Ji Kon Ryu; Yong-Tae Kim; Yong Bum Yoon; Joo Kyung Park
Journal:  Gut Liver       Date:  2012-11-13       Impact factor: 4.519

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.